Sopharma AD (SPH.WA)
PLN 13.0
(0.0%)
PLN 13.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 95.2 Million BGN | 34.95% |
| 2022 | 71.12 Million BGN | -20.53% |
| 2021 | 89.49 Million BGN | 200.27% |
| 2020 | 29.8 Million BGN | -65.74% |
| 2019 | 86.99 Million BGN | 206.93% |
| 2018 | 28.34 Million BGN | -29.14% |
| 2017 | 39.99 Million BGN | -21.01% |
| 2016 | 50.63 Million BGN | 137.58% |
| 2015 | 21.31 Million BGN | 5.63% |
| 2014 | 20.17 Million BGN | -31.01% |
| 2013 | 29.24 Million BGN | -16.9% |
| 2012 | 35.19 Million BGN | -8.35% |
| 2011 | 38.4 Million BGN | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 29.7 Million BGN | 62.91% |
| 2024 Q2 | 16.14 Million BGN | -45.66% |
| 2023 Q4 | 18.23 Million BGN | 27.71% |
| 2023 FY | 95.97 Million BGN | 34.95% |
| 2023 Q3 | 14.27 Million BGN | -54.25% |
| 2023 Q1 | 32.25 Million BGN | 590.66% |
| 2023 Q2 | 31.2 Million BGN | -3.24% |
| 2022 Q2 | 22.68 Million BGN | 9.69% |
| 2022 Q3 | 24.51 Million BGN | 8.09% |
| 2022 Q4 | 4.67 Million BGN | -80.95% |
| 2022 Q1 | 20.68 Million BGN | -46.93% |
| 2022 FY | 71.12 Million BGN | -20.53% |
| 2021 Q3 | 18.33 Million BGN | 30.45% |
| 2021 Q4 | 38.96 Million BGN | 112.52% |
| 2021 FY | 89.49 Million BGN | 200.27% |
| 2021 Q1 | 18.13 Million BGN | 128.64% |
| 2021 Q2 | 14.05 Million BGN | -22.5% |
| 2020 Q2 | 9.82 Million BGN | -9.03% |
| 2020 FY | 29.8 Million BGN | -65.74% |
| 2020 Q4 | 7.93 Million BGN | 532.54% |
| 2020 Q3 | 1.25 Million BGN | -87.23% |
| 2020 Q1 | 10.79 Million BGN | -79.71% |
| 2019 Q2 | 7.21 Million BGN | -53.25% |
| 2019 Q4 | 53.21 Million BGN | 378.09% |
| 2019 FY | 86.99 Million BGN | 206.93% |
| 2019 Q1 | 15.43 Million BGN | 1011.02% |
| 2019 Q3 | 11.13 Million BGN | 54.28% |
| 2018 Q2 | 8.43 Million BGN | -31.45% |
| 2018 FY | 28.34 Million BGN | -29.14% |
| 2018 Q1 | 12.3 Million BGN | 67.88% |
| 2018 Q3 | 6.21 Million BGN | -26.32% |
| 2018 Q4 | 1.38 Million BGN | -77.65% |
| 2017 Q1 | 17 Million BGN | -10.57% |
| 2017 Q3 | 3.76 Million BGN | -68.42% |
| 2017 Q4 | 7.32 Million BGN | 94.92% |
| 2017 FY | 39.99 Million BGN | -21.01% |
| 2017 Q2 | 11.9 Million BGN | -29.97% |
| 2016 Q2 | 15.86 Million BGN | 51.91% |
| 2016 FY | 50.63 Million BGN | 137.58% |
| 2016 Q1 | 10.44 Million BGN | 510.29% |
| 2016 Q4 | 19.01 Million BGN | 257.15% |
| 2016 Q3 | 5.32 Million BGN | -66.44% |
| 2015 FY | 21.31 Million BGN | 5.63% |
| 2015 Q4 | -2.54 Million BGN | 16.42% |
| 2015 Q3 | -3.04 Million BGN | -117.24% |
| 2015 Q2 | 17.66 Million BGN | 91.14% |
| 2015 Q1 | 9.24 Million BGN | 28778.13% |
| 2014 Q4 | 32 Thousand BGN | -98.41% |
| 2014 FY | 20.17 Million BGN | -31.01% |
| 2014 Q1 | 12.56 Million BGN | 890.94% |
| 2014 Q2 | 5.56 Million BGN | -55.72% |
| 2014 Q3 | 2.01 Million BGN | -63.83% |
| 2013 Q3 | 1.98 Million BGN | -82.3% |
| 2013 Q4 | -1.58 Million BGN | -180.25% |
| 2013 FY | 29.24 Million BGN | -16.9% |
| 2013 Q1 | 17.68 Million BGN | 2329.51% |
| 2013 Q2 | 11.18 Million BGN | -36.71% |
| 2012 Q1 | 11.33 Million BGN | 0.0% |
| 2012 FY | 35.19 Million BGN | -8.35% |
| 2012 Q3 | 11.4 Million BGN | -14.0% |
| 2012 Q4 | -793 Thousand BGN | -106.96% |
| 2012 Q2 | 13.25 Million BGN | 16.97% |
| 2011 FY | 38.4 Million BGN | 0.0% |
| Name | Net Income | Net Income Difference |
|---|